We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Endovenous RF Proves Superior to Vein-Stripping Surgery

By HospiMedica staff writers
Posted on 22 Oct 2003
Two separate randomized trials have found that endovenous radiofrequency (RF) obliteration provides significant advantages for patients with varicose veins compared to traditional vein-stripping surgery and that the benefits persist for two years following treatment. More...
The findings were presented at the German Society of Phlebology Congress in Nurnberg (Germany) by Professor Sanja Schuller-Petrovic, M.D., Ph.D., of the University of Vienna (Austria).

Two-year follow-up results of a multi-center randomized trial comparing the two methods showed that more than 91% of limbs treated with the RF procedure were free of reflux, the underlying cause of varicose veins. Neovascularization, a common cause of recurrence following vein stripping, was observed in only 3% of RF-treated patients compared to 17% of patients who had surgical vein stripping. Overall, RF patients had less pain and better improvement in physical activity than patients whose veins were stripped.

Shorter term results from a second trial were also summarized at the meeting. These showed that patients receiving the RF therapy experienced faster recovery, less pain, and returned to normal activities more than three times faster that patients whose veins were surgically stripped. More than 80% of the RF patients returned to normal activities within one day, compared to only 47% of surgery patients. The RF procedure, also known as the VNUS Closure procedure, was developed by VNUS Medical Technologies, Inc. (San Jose, CA, USA).

"There is now definitive proof that patients treated with the minimally invasive Closure procedure recover faster with less pain and fewer adverse events than patients treated with vein-stripping surgery,” said Brian Farley, president and CEO of VNUS Medical Technologies.




Related Links:
VNUS Medical

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.